TrialLancet (London, England)2015

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

Brent A Neuschwander-Tetri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.